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Past studies have focused attention on the lysosomal proteinases of polymor- 
phonuclear leukocytes (PMN) as mediators of vascular injury (1-6). A specific 
association between the hydrolases in these ceils and selected targets in vessel 
wails was suggested by Cochrane and Aiken, who showed that acid-cathepsins 
D  and E  extracted from rabbit PMN granules could digest vascular basement 
membrane in vitro (5). As pointed out by these same authors, acid-cathepsin- 
mediated vessel damage presupposes significant lowering of local pH. It remains 
to be determined whether sufficient acidity can be maintained at the tissue- 
blood interface to permit such reactions to occur in vivo. 
Recently, evidence has appeared of vascular damage by leukocyte proteinases 
with neutral pH optima. A neutral mucoproteinase has been detected in rabbit 
PMN  granules (7),  and neutral proteinases have been purified from Arthus 
edema fluid in this species  (8). Human neutrophiles are also known to contain 
neutral proteolytic activity or  "leukoprotease" (9-12).  We recently reported 
that extracts of human PMN granules could degrade vascular basement mem- 
brane at physiological pH in vitro and in vivo (6). Indeed, a neutral collagenase 
has been found in human PMN granules (13)  and may be responsible for the 
lysis of vascular basement membranes occurring at physiological pH. 
The present studies were undertaken to examine the neutral proteinases of 
human  neutrophilic  leukocytes  for  possible  activity  against  elastin.  This 
sialoprotein comprises the elastic lamina and supportive fibers present in the 
walls of arterial and major venous blood vessels. Such activity, if present, would 
help account for the development of arterial lesions in PMN-mediated arteritis. 
Our results show that the granules of human PMN contain neutral elastino- 
lyric activity which can be separated from the collagenolytic activity present 
in these cells. The data also demonstrate that the properties of elastolysis by 
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the PMN  agent are sufficiently different from those of elastolysis by pancreatic 
and serum-elastase as to suggest that the leukocyte factor is a distinct and sepa- 
rate  elastolytic  entity.  In  addition,  treatment  of human  tissues  in vitro with 
extracts  of  human  PMN  granules  will be  shown  to  cause  alterations  in  the 
elastica-staining properties of arterial vessels resembling the changes associated 
with  acute  arterifis. 
Materials and Methods 
Preparation of Leukocyte Frac~ions.--Freshly drawn  venous  blood  was  obtained  from 
normal male subjects between 20 and 35 yr of age, and was anticoagulated with citrate (75 ml 
of ACD solution-formula A per 500 ml). The blood was mixed with 2 volumes of cold, 3% 
dextran (clinicalgradeH) inisotonicNaC1, and erythrocytes were allowed to settle for 30 rain 
at 4°C.  Leukocytes were obtained  by centrifugation  of the dextran  supernatants,  in sili- 
conized bottles, at 160 g for 20 rain. Remaining erythrocytes were then lysed by hypotonic 
shock in 0.21% NaC1 for 30 see. Lysis was terminated by addition of KC1 to a final concen- 
tration of 0.15 5. All procedures were carried out between 0  ° and 4°C. Average yields per 500 
ml whole blood equaled 20 X  108 total leukocytes, of which 65-75% were PMN. 
After one wash in 0.34 x~ sucrose,  the leukocytes were suspended in a small volume of the 
same  solution  (1  ml per 2  ×  l0  s PMN)  and  mechanically disrupted  by vacuum suction 
through a flue wire screen (0.25 mm  9" openings). A small aliquot of undiluted homogenate was 
centrifuged at 17,000 g X  20 rain to obtain a sample of the granule-free, cell sap fraction. The 
remainder of the homogenate was diluted with excess sucrose solution and was subjected to 
differential centrifugation. After discarding unbroken cells at 180 g, nuclei and granules were 
collected at 500 g and 17,000 g respectively. They were then separately resuspended in 0.15 
sodium  phosphate  buffer  (pH  8.0)  and  disrupted  by repeated freeze-thawing. After high- 
speed centrifugation to sediment debris, the clarified supernatants of lysed nuclei and granules 
were dialyzed 5 hr against cold, normal saline containing 0.01  xt phosphate  (pH 7.4).  The 
dialyzed extracts were stored at -60°C until used. The cell sap fraction of the homogenized 
leukocytes was similarly freeze-thawed, dialyzed, and stored at -60°C. 
Blood, "free" of PMN, was also required as a control preparation. In these experiments, 
freshly-drawn, heparinized human blood was filtered at 37°C through a  sterile, nylon-wool 
column (Leuko-Pak, Fenwal Laboratories, Inc. Morton Grove, Ill.). Differential staining re- 
vealed 2% or less of PMN. Platelets, erythrocytes, and lymphocytes were unaffected by this 
procedure. Thereafter, treatment of the blood was as described earlier. 
Pancreatic Elastase (Pamreatopeptidase  E, EC 3.4.4.7).--The  elastase used in our experi- 
ments was a 2X crystallized preparation made from swine pancreas (Worthington Biochemical 
Corporation, Freehold, N. J.). 
Anti-protease Agents.--Soybean  trypsin  inhibitor was  obtained  from  Worthington  Bio- 
chemical Corporation. Salivary kallikrein inhibitor (Trasylol, preparation A-128) was obtained 
from FBA Medical Research Division of Metachem, Inc., N. Y. 
Protein Assay.--Protein content of leukocyte fractions and column eluates was measured 
with the Folin-Ciocalteu reagent according to the method of Lowry (14). Crystalline ("anti- 
gen")  bovine  serum  albumin  (Pentex  Incorporated,  Kankakee,  IlL)  served  as  reference 
standard. 
Elastase Assay.--Elastolysis  by leukocyte fractions and by pancreatic elastase was meas- 
ured by the method of Sachar (15), in which dyed, solid elastin is solubilized by the enzyme 
and released dye is measured colorimetrically. For this purpose, orcein-dyed elastin (Worth- 
ington Biochemical Corporation) was employed as substrate at a concentration of 10 mg/ml 
in the desired buffer.  The latter was usually 0.2  ~  Tris-HC1,  pH 8.8 (at 37°C).  Other buffer A.  JANOFF  AND  J.  SCHERER  1139 
systems will be described elsewhere in the text. Length of incubation was  routinely 2  hr 
(37°C) unless otherwise specified. Buffer pH was adjusted at the incubation temperature. 
In experiments involving measurement of elastolysls in the presence of serum, a modification 
of the assay method was required to eliminate colorimetric interference by serum pigments. 
For this purpose, TCA precipitation of serum proteins, followed by extraction of free orcein 
into butanol, was carried out according to the method of Chao (16). The optical density of the 
butanol phase was then taken as a measure of elastolysis. 
Protedysis Assay.--Assays of proteolytic activity using denatured hemoglobin as substrate 
(Nutritional  Biochemical Corporation,  Cleveland,  O.),  were  carried  out  according to  the 
method of Anson (17)  as modified by Press (18). A  1.7% solution of hemoglobin in 0.06 M 
sodium phosphate buffer (pH 7 at 37°C) was divided into 1.0 ml aliquots in duplicate assay 
tubes. Appropriate quantifies (See Results) of the materials to be tested were added, and the 
tubes were incubated for 60 rain at 37°C. Reactions were stopped by addition of 0.9 ml of 
0.3 u  TCA per tube, and the optical density of the TCA supernatants was read at 280 m/t. 
Absorption blanks were prepared by addition of test materials to substrate tubes after incuba- 
tion and TCA precipitation steps. 
Elastolysis Inkibition Experiments.-- 
pH: Inhibitory effects of decreasing pH were studied in tris-acid maleate buffer (Trizma 
maleate,  Sigma Chemical Company,  St.  Louis,  Mo.)  and in sodium, potassium phosphate 
buffer. Molarity of both buffers was varied in order to keep ionic strength constant at 0.05 at 
all pH values. Concentration of test materials are given in the Results section. 
Ionic strength: Inhibition by increasing ionic strength was tested in 0.2 xf Tris-HCl buffer 
(pH 8.8 at 37°(2)  containing different concentrations of NaC1. 
Serum: Inhibition by added serum was determined in 0.2 ~s Tris-HCl buffer (pH 8.8), or in 
phosphate-buffered saline (pH 7.4). Total ionic strength of the latter system was uniformly 
kept at 0.1 by mixing a constant volume of phosphate buffer (I =  0.05) with variable quanti- 
fies of serum and normal saline such that the sum of the volumes of these latter ingredients 
was also constant and equal to that of the phosphate buffer. Serum concentration varied be- 
tween 0.1 and 50°7o. The human serum was either freshly drawn or else had been stored at 
--20°C for less than 1 wk before use. Orcein liberated by elastolysis in the presence of serum 
was measured by the butanol extraction method of Chao (16). 
Tissue Experiments.--Portions  of human kidneys and renal arteries were obtained post- 
mortem. 6-/J thick sections of kidney were cut on a  freezing microtome and transferred to 
glass slides. Control sections were covered with 1-2 drops of normal saline plus 0.01 ~x phos- 
phate buffer (pH 7.4 at 37°C). Other sections were covered with buffered saline containing 400 
/zg/ml of PMN granule protein. The slides were placed in moist chambers and incubated at 
37°C. At 2-hr intervals, the sections were drained and covered with fresh test solutions. Incu- 
bation was continued for a total of 6 hr. Renal arteries were treated as follows: After dissecting 
away adherent fat and washing in ice-cold saline to remove traces of blood, the vessels were cut 
into 2-ram wide strips. Individual strips were then incubated in 0.075 u, pH 7.8 tricine buffer 
(N-tris,  hydroxymethyl  methyl  glycine,  Calbiochem  Corporation,  Los  Angeles,  Calif.). 
PMN granule protein (450 ~ug/ml) was added to selected arterial strips, and incubation was 
continued for 90 min at 37°C. 
Following incubation, kidney sections and artery strips were fixed overnight in 10% neutral 
formalin. The arterial tissue was dehydrated, imbedded in parg~n~ and sectioned. Frozen sec- 
tions of kidney were stained directly. Weigert's resorcin-fuchsin elastic tissue stain was used, 
and counterstaining was done with van Gieson's solution (19). Parallel kidney sections were 
also stained with hematoxylin and eosin to facilitate the selection of appropriate vessels for 
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RESULTS 
1. Demonstration  of Elastinolytic  Activity in Human PMN  Granules.--Table 
I summarizes the results obtained when fractions of human leukocyte homoge- 
nates and other agents were incubated with orcein-dyed elastin as described in 
Materials and Methods. Activities of the different materials tested are expressed 
TABLE I 
Elastolysis by Human Leukocyte Fractions and Other Agents 
Test material  Protein concentration  Elastolysis*, 
% 
A. Leukocyte homogenate (65-75% PMN) 
Granules 
Nuclei 
Cell sap 
B. PMN-depleted leukocyte homogenate (2% 
PMN) 
Granules 
C. Purified proteolytic enzymes 
Trypsin 
Chymotrypsin 
Papain 
Elastase§ 
•g/ml 
500 
500 
500 
500 
25 
25 
25 
25 
100 
15 
6 
0 
0 
0 
100 
* Expressed as per cent of the elastolysis given by 25 #g of pancreatic elastase in the same 
experiment. 
:~ Elastolysis reactions carried out for 2 hr in 0.2 M Tris-HC1 buffer (pH 8.8 at 37°C) 
containing 10 mg orcein-elastin per milliliter. 
§ 2 X crystallized pancreatopeptidase E (EC 3.4.4.7) (Worthington Biochemical Corp., 
Freehold, N. J.). 
as per cent of the elastolysis given by a  fixed amount of purified pancreatic 
elastase.  Assay conditions were kept constant  throughout all experiments.  It 
can be seen from part A  of Table I  that significant elastinolytic activity was 
detected in the granule fraction of the leukocyte homogenates. Similar results 
were obtained with separate granule preparation from 10 leukocyte donors. On 
an equal weight basis, granule protein consistently possessed about 1/~ 0th of the 
activity of the purified pancreatic enzyme. Specific activity of the granules (see 
Table I) was high in comparison with that of nuclear and cell sap fractions, as 
was total elastolytic activity of the granule fraction (specific activity X  total 
protein content of the fraction). The latter value was found to be four times 
greater than total cell sap activity. 
Part B  of Table I  shows that granules prepared from PMN-depleted blood A. JANOI~F AND  J'.  SCIIERER  1141 
(see Materials and Methods) were almost entirely devoid of elastinolytic activ- 
ity, suggesting  that the granule fraction of PMN leukocytes is the source of the 
active agent. In addition to loss of specific granule activity following the elimi- 
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nation of PMN from the starting blood, profound reductions (95 %) in total 
yield of granule protein also occurred. 
In part C of Table I it can be seen that the assay system employed was specific 
for elastinolytic enzymes. 
2. Effect of Decreasing pH on tke Elastlnolytic Activity of PMN Granules and 
Pancreat~  Elastase.--The  activity of pancreatic  elastase is maximal  at  pH 1142  ELASTOLYSIS BY HUMAN  LEUKOCYTE  GRANULES 
8.5-8.8,  but becomes inhibited as pH approaches neutrality.  This property of 
the  pancreatic  enzyme  reduces  its  potential  effectiveness as  a  mediator  of 
elastolysis in acute arterial inflammation. A series of experiments were therefore 
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performed to determine the effect of decreases in pH on the elastinolytic activity 
of human PMN granules. Two buffer systems were employed in these experi- 
ments and the ionic strength of both buffers was kept constant at all pH values 
tested. This was necessary in view of the independent inhibition of elastolysis 
which results from increasing ionic strength (see Results, part 3). Per cent in- 
hibition at lower pH values was calculated in relation to the elastolysis present 
at pH 8.5,  the latter value being arbitrarily taken as 100% activity. A.  JANOrF AND  J.  SCr~ERER  1143 
The results are depicted  in Fig.  1,  in which inhibition of elastolysis by de- 
creasing pH is shown for both the pancreatic and leukocyte agents.  It can be 
seen that in both buffers the PMN granule extract was inhibited about 50 % at 
pH  7  and  approximately  75 %  at  pH  6.  On  the  other hand,  the  pancreatic 
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elastase  preparation was 80%  inhibited  at pH  7  and  was nearly  completely 
inhibited  at pH  6.  Thus,  at pH values which might be  expected  to  exist  in 
inflamed arterial wails,  greater activity  is retained by the PMN  elastinolytic 
factor than by the pancreatic enzyme. 
3. Effect  of Increasing  Ionic  Strength  on  the  Elastinolytic  Activity  of PMN 
Granules and Pancreatic Elastase.--In addition to the inhibitory effect of phys- 
iological pI-I upon  pancreatic  elastase  shown in the preceding  section,  phys- 
iological concentrations of NaC1 also inhibit this enzyme (20).  Thus in Fig.  2 
it can be seen that at its pH optimum (8.8)  the pancreatic enzyme is 70%  in- 
hibited  by  an  isotonic concentration of NaC1.  We  therefore investigated  the 1144  ELASTOLYSIS  BY  HUMAN  LEIYKOCYTE  GRANULES 
effect of increasing ionic strength  on the  elastinolytic activity of leukocyte 
granules. As seen in Fig. 2, the granule extract was partly inhibited both at low 
and high concentrations of NaC1, but was completely uninhibited at a  physio- 
logic concentration of this salt.  This marked difference in the effect of ionic 
strength on the pancreatic and leukocyte elastinolytic agents lends further sup- 
port to the suggestion that the latter agent is the potentially more important 
mediator of vessel wall elastolysis in vivo. 
4. Effect of Serum Elastase Inhibitor  on Elastolysis  by PMN Granules and 
Pancreatic Elastaze.--A potent inhibitor of pancreatic elastase is present in the 
sera of most animal species,  including man (16, 20). We therefore explored the 
effect of human serum upon the elastinolytic activity of both the pancreatic 
and the human leukocyte agents. The results are shown in Fig. 3.  It can be 
seen that pancreatic elastase (20 #g/ml) was inhibited 75 % by a  1% concen- 
tration of fresh human serum in the incubation mixture. Complete inhibition of 
the action of this enzyme upon elastin was observed in the presence of 2 % 
serum. These reactions were carried out in 0.2 ~ tris-HC1 buffer, pH 8.8 at 37°C. 
Under the same conditions, leukocyte granule extract (200/~g protein/ml) was 
not inhibited by 1% serum and was only inhibited 18 % in 2 % serum. Inhibition 
of the leukocyte elastinolytic agent was still incomplete (60 %) at a 5 % serum 
concentration. These results are even more significant in view of the fact that 
200/~g of leukocyte granule protein contains only half the effective elastolytic 
activity of 20 ~g of crystalline pancreatic enzyme (see Results, part 1). 
A second serum inhibition experiment (also shown in Fig. 3) was then carried 
out in a phosphate buffer-saline-serum system (combined ionic strength =  0.1, 
pH  =  7.4,  see Materials and Methods). This incubation medium eliminated 
variations  in  ionic  strength  and  pH  caused  by  the  addition  of  larger 
amounts  of  serum  (over  5%)  to  the  tris-HCl buffer used  in  the  previous 
experiment.  Under  these  conditions, pancreatic  elastase was  completely in- 
hibited at the start by the combined effects of high ionic strength and neutral 
pH, without addition of any serum. The leukocytic agent, on the other hand, 
again demonstrated greater resistance to the action of serum-elastase inhibitor 
(see Fig. 3). 
Thus, the leukocyte granule elastinolytic factor appears to be significantly 
less susceptible to the action of circulating elastase inhibitor than is the pan- 
creatic enzyme. This observation, as well as the findings presented in the sections 
on pH inhibition and ionic strength inhibition, provide arguments favoring the 
leukocyte as a  major source of pathological elastolytic activity. 
5. Effect of Antlprolease Agents on the Elastinolytic Activity of PMN Granules 
and  Pancreatic Elastase.--Soybean  trypsin  inhibitor  and  salivary kallikxein 
inhibitor are reportedly ineffective against the  elastinolytic activity of pan- 
creatic elastase, although these same anfiprotease agents can block the non- 
specific proteolytic activity associated with the enzyme (20). When the above- A.  JANOI~F  AND  J.  SCHERER  1145 
mentioned  inhibitors were also tested on human  PMN  granules, marked 
inhibition  of  elastolysis  was observed.  These results  are  summarized ill  Table II. 
As shown, small quantities  of  pancreatic  enzyme (5  ~g/ml) retained  full  elasto- 
lyric  activity  in  the  presence of  relatively  large  amounts of  inhibitory  agents.  In 
contrast,  PMN  granule activity  was inhibited  50% by the highest concentra- 
tions of the same inhibitors.  All reactions  were conducted in tris-HCl buffer 
under optimal conditions  for elastolysis  (low ionic  strength and alkaline  pH). 
6. Effect of Ionic Strength, Serum, and Antiprotease  Agents on the Hemoglobin- 
Digesting Activity of Human PMN Granules and Pancreatic Elastase.--We next 
TABLE II 
Effect of Antiprotease Agents on Elastolysis* 
Teat agent 
Soybean trypsin  inhibitor, 
~,g/ml 
Salivary  kMllkrein  inhibitor, 
units/ml 
Concentration 
50 
100 
500 
200 
2000 
% inhibition~: 
Pancreatic  elastase 
(5 ~g/ml) 
PMN granule extract 
(450 #g protein/ml) 
19 
24 
49 
0 
49 
* Reactions carried  out in 0.2 •  tris-HC1 buffer (pH 8.8 at 37°C) containing  10 mg orcein- 
dyed elastin per ~!lliliter. 
:~ Based on values of orcein released in the absence of protease inhibitors. 
tested increasing ionic strength and fresh human serum for their effects on the 
hemoglobin-digesting activity of PMN granules and pancreatic elastase. The 
results are shown in Table III. As expected, concentrations of saline which 
interfered  significantly with  elastolysis by  the  pancreatic  preparation  (see 
part 3 of Results) had no discernible effect on the hemoglobin-digesting activity 
of the same preparation. Neither did these same concentrations of salt inhibit 
hemoglobin digestion by PMN granule extracts. Again, as expected, addition 
of fresh serum inhibited proteolysis by the pancreatic elastase complex, and the 
same concentrations of serum also inhibited (although to a lesser extent) the 
proteolytic activity of PMN granules. Finally, as shown in Table III, soybean 
trypsin inhibitor also partially inhibited hemoglobin digestion by PMN granule 
extracts. 
7. Preliminary  Separation  of  Elastinolytic  and  Collagenolytic  Activities  of 
Human PMN Granules.--Elastin  is not significantly affected by any known 
protease other than elastase.  Nevertheless,  we attempted to distinguish the 
elastinolytic agent of human PMN granules from the collagenase also present 1146  ELASTOLYSIS  BY  HUMAN  LEUKOCYTE  GRANULES 
in  these  particles  (13).  A  preliminary separation  of the  two  activities  was 
achieved by using ion-exchange, column chromatography on  CM-Sephadex. 
21 mg of granule protein were concentrated into a volume of 1 ml and dialyzed 
against 0.01 M barbital buffer, (pH 8.46 at 4°C). Precipitated material was re- 
moved by centrifugation and the clarified sample was placed on a 0.9 X  15 cm 
column containing 2.0 g of CM-Sephadex (C-25) previously equilibrated with 
the buffer. After two complete bed volumes of the buffer had passed through 
the column, a  step-wise gradient of NaCI in barbital buffer was started.  All 
procedures were  carried  out  at  4°C.  Protein  eluting  from  the  column  was 
monitored with the Folin assay. 
TABLE III 
Effe¢t of Various Inhibitors  on Proteolysis* by PMN and Pancreatic Elastinotyt~  Extracts 
Inhibitor 
NaC1, 
Human serum~ 
Soybean trypsin  inhibitor, 
#g/ml 
Concentration 
0.15 
0.30 
50 
500 
% inhibitions 
Pancreatic elastase 
(4 pg/mi) 
81 
93 
PM2~" granule extract 
(40 t~g protein/ml) 
60 
60 
0 
63 
* Hemoglobin digestion assay as described in Materials and Methods. 
:~ Based on values of TCA-soluble  peptides released  in the absence  of inhibitors. 
An initial peak containing 1.7 mg of protein appeared just after the column- 
void.  This  peak  contained  no  detectable  elasfinolytic activity  and  only  a 
negligible amount of hemoglobin-digesting activity, but accounted for half of 
the total collagenase present in the starting granule extract (bovine Achilles 
tendon substrate; ninhydrin assay). Additional protein was then recovered in 
four broad  peaks  during  between  0.1  and  0.45  za NaC1.  Elastinolytic  and 
hemoglobin-digesting activities were found in the fractions eluting with 0.45 
NaC1. These observations, although preliminary, suggest that the collagenase 
and the elastinolytic agent of human PMN granules are separate entities. The 
further purification of PMN-elastase will be reported elsewhere,  t 
8. Effect  of  PMN  Granule  Extracts  on  the  Elastica-Staining  Properties  of 
Human  Arteries  In  Vitro.--Frozen  sections  of human  kidney and  strips  of 
a Janoff, A. Mediators of inflammation in leukocyte lysosomes.  X. PMN elastase: partial 
purification and further study of effects  upon elastic tissue. Manuscript in preparation. A.  JANO~F AND  .]'. SCH'F__,R.ER  1147 
human  renal  artery  were incubated  with  human  PMN  granule  extracts  as 
described in Materials and Methods. Control tissues were incubated in buffers 
alone.  Mter designated intervals, the tissues were fixed and stained for elastic 
fibers (see Materials and Methods). A considerable  reduction in the intensity of 
elastica staining was consistently observed in muscular vessels of intermediate 
caliber in kidney sections exposed to the action of the granule extract. Repre- 
sentative results are shown in Figs. 4 b and 4 d. Many smaller caliber arteries 
were almost completely denuded of their  elastic lamellae  and  could only be 
observed with difficulty in sections stained for elastic tissue.  In general,  the 
same vessels were compared in  adjacent tissue sections (see  Figs.  4 a--4 d). 
Relatively short exposure of renal artery strips to the action of the granule 
extract  frequently  resulted  in  partial  fragmentation  of  the  internal  elastic 
lamina and separation of this layer from the underlying smooth muscle cells 
(see Figs.  5a-d). 
Thus, treatment of human arterial vessels in vitro with extracts of human 
PMN granules caused alterations in elastic elements resembling those found in 
PMN-mediated arteritis. A comparison of the effects of purified PMN and pan- 
creatic  elastases upon arterial  elastic tissue under  physiologically inhibitory 
conditions (serum, ions, pH) will be the subject of a separate report. 1 
DISCUSSION 
Pancreatic elastase is not only capable of carrying solid elastin into solution, 
but is also capable of digesting a  variety of soluble protein  substrates  (e.g. 
hemoglobin, casein, fibrin).  Ling (21) has recently separated the two activities 
into  a  specific elastinolytic enzyme and  a  second enzyme with  broad,  non- 
specific proteolytic activity. The latter, however, demonstrates relatively low 
affinity for many synthetic substrates  of proteolysis. Human PMN  granule 
extracts also digest hemoglobin and fibrin  at neutral pH and yet show little 
activity against several synthetic substrates of proteolysis (6). Moreover, this 
nonspecific proteinase activity of PMN granule extracts is associated with the 
elastinolytic and not the collagenolytic fractions of the extract, when these are 
separated as described earlier.  In the foregoing  respects, "leukocyte-elastase" 
resembles the elastase complex present in pancreatic tissue. 
Despite the above-mentioned similarity,  the data presented in this report 
show that the elastolysis reactions mediated by human PMN granule extracts 
and porcine pancreatic elastase can be distinguished in several ways. The two 
reactions clearly differ with respect to pH effects, salt inhibition,  and sensitivity 
to inhibition by serum or antiprotease drugs.  These observations suggest that 
leukocyte granules contain an elastinolytic factor different from that  which is 
present in pancreas  (assuming that human pancreatic elastase has properties 
similar  to those of the pancreatoelastases of other species).  Serum elastase is 
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the latter  tissue  (22).  The same properties which  distinguish  the leukocyte 
enzyme from the pancreatic one can therefore serve to differentiate "leukocyte 
elastase"  from  serum  elastase.  Accordingly,  it  would appear  unlikely  that 
PMN granule elastinolytic activity reflects pinocytosis of serum proteins by 
circulating  leukocytes followed by storage of the serum enzyme within  the 
lysosomes of these cells. 
For the present,  therefore, we have assumed that human PMN lysosomes 
contain an elastinolytic factor which is independent of that found in serum and 
pancreatic tissue.  It remains to be determined whether this PMN-elastinolytic 
agent actually participates in vivo in elastolysis associated with acute arteritis. 
However, the following considerations at least favor this view. In those forms 
of arterifis thought to be associated with an immune pathogenesis,  PMN may 
be attracted  to the internal  elastic lamina  of the artery wall  following  sub- 
endothelial deposition of chemotactically-active, circulating immune complexes 
(23). High concentrations of PMN granule--elastase  can then be released in the 
immediate vicinity of the elastica components in the underlying tunica media. 
Release of PMN granule proteinases into  the extraeeUular  environment has 
been shown to occur upon addition of immune complexes to leukocyte suspen- 
sions in vitro (3, 6). Local concentrations of "leukocyte elastase" which could 
develop under  these conditions might  rapidly overcome the effect of serum 
elastase inhibitor,  a  process which would be facilitated by the relatively low 
sensitivity of the PMN enzyme to this latter agent. (Serum elastase might also 
take part in the pathological elastolysls reaction,  if serum elastase inhibitor 
became sufficiently diluted in  inflammatory  exudate fluids.  However, under 
these conditions,  the leukocyte enzyme by virtue of its higher  threshhold  of 
inhibition would be activated much sooner.)  Other properties of the inflamed 
arterial tissue, such as slightly acid pH values and physiological concentrations 
of ions, would further favor the action of "leukocyte-elastase" over that of the 
serum enzyme. 
The possible role of PMN lysosomal acid-cathepsins in pathological elasto- 
lysis reactions also requires consideration.  Thomas  (24)  reported partial  deg- 
radation  of cartilage  elastic  fibers  after  treatment  with  the  acid-protease, 
papain;  while Hall (25) showed that pepsin could gradually solubilize  elastin 
in vitro. However, the digestion of elastin by these acid-proteases was extremely 
slow in comparison with digestion by bacterial or pancreatic elastases,  or by 
human leukocyte extracts in our studies. Elastase has thus been recognized  as 
the chief proteinase capable of carrying solid elastin into solution at rates ap- 
proaching  those normally associated with specific  enzyme-substrate interac- 
tions. Furthermore, the pH present in blood vessel walls, even in the presence of 
inflammatory response, is probably sufficiently stabilized by the passing plasma 
stream as to be close to the neutral range.  The "leukocyte elastase" is still 
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acid-cathepsins to act is far lower. Therefore, the detection of an elastinolytic 
factor in human PMN granules,  with the ability to retain  appreciable activity 
in the presence of physiological  concentrations of salts, neutral to slightly acid 
pH,  and  moderate titers  of serum elastase inhibitor,  provides an  attractive 
mechanism to account for PMN-mediated elastolysis during acute arteritis. A 
slow attack  upon  elastin  by the acid-cathepsins  of neutrophils  may play a 
supplementary role in this process. 
In conclusion, at least two pathologically important neutral-proteinases have 
now been found in human PMN granules:  a collagenase (13) capable of ruptur- 
ing basement membranes leading to hemorrhagic vasculitis, and an  elastino- 
lyric agent which may attack elastic lamina during acute arteritis.  The  com- 
plementary actions of these two enzymes upon the two major supportive con- 
stituents of connective tissues (collagen and elastin), could account for a major 
part  of  connective  tissue  destruction  associated  with  acute  inflammatory 
disease. 
S~,RY 
The present study demonstrates that a granule fraction derived from human 
polymorphonuclear  leukocytes possesses elastinolytic activity,  and  that  the 
latter can be separated from the collagenase  present in these cells. Properties 
of the human  leukocyte elastase differ  sufficiently from those of pancreatic 
elastases of different species as to suggest that the former enzyme is a distinct 
and  separate entity. Thus,  soybean trypsin inhibitor  and  salivary kallikrein 
inhibitor (Trasylol) fail to inhibit elastolysis by the pancreatic enzyme, but do 
inhibit  the  leukocyte  elastinolytic  agent.  Elastolysis  by human  leukocyte 
granule extract does not show significant  salt inhibition, whereas that catalyzed 
by pancreatic elastase is markedly reduced when ionic strength is increased to 
physiological levels.  The leukocyte granule extract is at least 10 times more 
resistant  to serum elastase inhibitor  than is the purified  pancreatic enzyme. 
Both enzymes show optimal elastolysis above pH 8.5, but the leukocyte factor 
still retains  50% of its maximal  elastolytic activity at pH 6-7; whereas the 
activity of the pancreatic enzyme falls to 10% or less of its maximal value under 
the  same  conditions.  The  foregoing  characteristics  of the human  leukocyte 
elastase suggest that it, rather than pancreatic (serum) elastase,  may mediate 
pathological elastolysis during acute arteritis in man. In keeping with this sug- 
gestion,  the present  experiments  also show that  elastica staining  of human 
arterial  vessels  is  reduced  by incubation  of  tissues  with  human  leukocyte 
granule extracts in vitro. 
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FIGS. 4 a-4 d. Effect of PMN granule extracts on the elastica staining of arteries in 
vitro. Vessels in frozen sections of human kidney. 
FIG. 4 a. Control vessel after 6 hr of incubation in normal saline containing 0.01 
sodium phosphate buffer (pH 7.4 at 37°C). L, elastic lamellae; F, elastic fibers. Weig- 
ert's elastic tissue stain,  ×  215. 
FIG. 4 b.  Identical vessel in adjacent tissue section. Note decreased elastica staining 
after 6  hr of incubation in phosphate saline containing 400  /~g/ml of human  PMN 
granule protein. Weigert's elastic tissue stain, X  215. 
FIG. 4  c.  Portion of a  different control vessel after incubation as in Fig. 4a. Wei- 
gert's elastic tissue stain,  X  215. 
FIG. 4  d.  Identical vessel in  adjacent tissue  section,  showing  decreased  elastica 
staining after incubation as in Fig. 4 b. Weigert's elastic tissue stain, ×  215. 1153 1154  ELASTOLYSIS  BY  HUMAN  LEUKOCYTE  GRANULES 
FIGS. 5 a-5 d.  Effect of PMN granule extracts on the elastica staining of arteries in 
vitro.  Human renal artery. 
FIG. 5 a.  Control segment of renal artery after  1~/~ hr  of incubation in 0.075  M 
tricine buffer (pH  7.8 at 37°C). INT, elastica interna, M,  tunica media, and EXT, 
elastica externa. Paraffin section, Weigert's elastic tissue stain,  ×  440. 
FIG. 5 b.  A different segment of the same renal artery showing fragmentation of the 
elastica interna after  11/~ hr  incubation in tricine buffer containing 450  #g/ml  of 
human PMN granule protein. Paraffin section,  Weigert's elastic tissue stain,  X  440. 
FIG.5 c. Higher magnification  of elastica interna of control arterial segment. X  1760. 
FIG. 5 d.  Higher magnification  of elastica interna of arterial segment incubated with 
granule extract. Note detachment of elastica interna from the underlying  tunica media, 
as well as fragmentation of the elastic membrane. X  1760. 1155 